Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reissue Patent
2007-08-07
2007-08-07
Owens, Amelia A. (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S090000
Reissue Patent
active
11299244
ABSTRACT:
Polyketide compounds of the formula but not including FK-506, FK-520, 18-hydroxy-FK520 and 18-hydroxy-FK-506.
REFERENCES:
patent: 4874748 (1989-10-01), Katz et al.
patent: 5063155 (1991-11-01), Cox et al.
patent: 5098837 (1992-03-01), Beckmann et al.
patent: 5149639 (1992-09-01), Katz et al.
patent: 5189042 (1993-02-01), Goulet et al.
patent: 5672491 (1997-09-01), Khosla et al.
patent: 5712146 (1998-01-01), Khosla et al.
patent: 5824513 (1998-10-01), Katz et al.
patent: 5830750 (1998-11-01), Khosla et al.
patent: 5843718 (1998-12-01), Khosla et al.
patent: 5962290 (1999-10-01), Khosla et al.
patent: 5968921 (1999-10-01), Gold
patent: 6022731 (2000-02-01), Khosla et al.
patent: 6077696 (2000-06-01), Khosla et al.
patent: 6150513 (2000-11-01), Wu
patent: 6210974 (2001-04-01), Gold
patent: 0 184 162 (1986-06-01), None
patent: 0323042 (1989-07-01), None
patent: 0356399 (1990-02-01), None
patent: 0463690 (1992-01-01), None
patent: WO 93/13663 (1993-07-01), None
patent: WO 95/08548 (1995-03-01), None
patent: WO 96/40968 (1996-12-01), None
patent: WO 97/02358 (1997-01-01), None
patent: WO 98/27203 (1998-06-01), None
patent: WO 98/49315 (1998-11-01), None
patent: WO 00/2000 (2000-04-01), None
patent: WO 00/20601 (2000-04-01), None
Chen, TS et al (1992) ‘Microbial Transformation of Immunosuppressive Compounds. II. Specific desmethyltion of 13-methoxy group of FK 506 and FR 9500520 byActinomycetesp. ATCC 53828,’ J. Antibiot 45(4):577-580.
Dumont, FJ et al (1992). ‘The Immunosuppressive and Toxic Effects of FK-506 Are Mechanically-Related: Pharamacology of a Novel Antagonist of FK-506 and Rapamycin,’ J of Exp Medicine 179(3):751-760.
Fu et al, 1994, Biochemistry 33:9321-9326.
Iwasaki et al, (1993) Drug Metabolism and Disposition 21:971-977.
Iwasaki et al, (1995) Drug Metabolism and Disposition 23:28-34.
Kawai et al, (1993) FEBS Letters 316(2):107-113.
Kholsa C. (1997). ‘Harnessing the Biosynthetic Potential of Modular Polyketide Synthases,’ Chemical Reviews 97(7):2577-2590.
Motamedi et al, (1996) J. Bacteriol. 178:5243-5248.
Motamedi et al, (1997) Eur J Biochem 244:78-80.
Motamedi and Shafiee, (1998) Eur J Biochem 256:528.
Reynolds KA et al (1997) ‘Rapaycin, FK506 and Ascomycin-related Compounds,’ Drugs Pharm Sci 82:497-520.
Shafiee, A et al (1993) ‘Enzymatic Synthes and Immunosuppressive Activity of Novel Desmethylated Immonomycins (Ascomycins),’ J Antibiot 46(9):1397-1405.
Stassi, DL et al (1998). ‘Ethyl-substituted Erythromycin Derivatives Produced by Directed Metabolic Engineering,’ Proc Natl Acad Sci USA 95 (13):7305-7309.
Wu et al, (200) Gene 251:81-90.
Iwasaki et al, (1995), Further metabolism of FK506 (tacrolimus); Identification and biological activities of the metabolites oxidized at multiple sites of FK506, Drug Metabolism & Disposition 23:28-34.
Iwasaki et al, (1993), Isolation, identification and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone, Drug Metabolism & Disposition 21:971-977.
Kawai et al, Jan. 1993, Structure-activity profiles of macrolactam immunosuppressant FK-506 analogues, FEBS Letters 316(2):107-113.
Motamedi et al , 1998, The biosynthetic gene cluster for the macrolactone ring of the immunosuppressnt FK506, Eur J Biochem 256:528-534.
Motamedi et al, 1997, Structural organization of a multifunctional polyketide synthase involved in the biosynthesis of the macrolide immunosuppressant FK506, Eur J Biochem 244:74-80.
Motamedi et al, 1996, Characterization of methyltransferase and hydroxylase genes involved in the biosynthesis of the immunosuppressants FK506 and FK520, J Bacteriol 178:5243-5248.
Caffrey et al, FEBS Letters (1992) 34:205.
Fu et al, Biochemistry (1994) 33:9321-9326.
McDaniel et al, Science (1993) 263:1546-1550.
Rohr, Angew Chem Int Ed Engl. (1995) 34(8):881-888.
Gold et al., Journal of Neuroscience (1995) 15:7509-7516.
Gold et al., J. Pharm. Exp. Ther. (1999) 289(3):1202-1210.
Harrison's Principles of Internal Medicine, 14th edition, McGraw Hill (1998) Ch. 14, 20, 21 and 64-67.
Lyons et al., Proc. Natl. Acad. Sci. USA (1994) 91:3191-3195.
Shiraga et al., Biochem. Pharmacol. (1994) 47:727-735.
Steiner et al., Proc. Natl. Acad. Sci. USA (1997) 94:2019-2024.
Vincent et al., Arch. Biochem. Biophys. (1992) 294:454-460.
Wu et al., Gene (2000) 251:81-90.
Chu Daniel
Khosla Chaitan
Reeves Christopher
Santi Daniel
Wu Kai
Kosan Biosciences, Inc.
Morrison & Foerster / LLP
Owens Amelia A.
LandOfFree
Polyketide synthase enzymes and recombinant DNA constructs... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polyketide synthase enzymes and recombinant DNA constructs..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyketide synthase enzymes and recombinant DNA constructs... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3883367